NASDAQ
Immunome, Inc. (IMNM) has a fcf yield of -10.69% as of Friday, May 29, 2026. This represents a 71.60% increase compared to its 12-month average of -37.64%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.